CompanyMedical Device

Sisram Medical’s Alma Veil Launches in the US for Vascular Lesion Treatment

CompanyDrug

AstraZeneca’s Eplontersen Gains Tacit Approval from CDE for ATTR-CM Clinical Study

CompanyDeals

Kanova Biopharma Secures Over RMB 100 Million in Financing for Autoimmune and Oncology Pipeline

CompanyDrug

Boehringer Ingelheim Gets NMPA Approval for Phase II Study of BI 764532 in SCLC

CompanyDrug

HanchorBio’s HCB101 Receives WFDA Approval for Multi-Region Clinical Study

CompanyDeals

Sosei Heptares Acquires Idorsia’s Korea and Japan Units in JPY 65 Billion Deal

CompanyDrug

InnoCare Pharma’s ICP-723 Receives NMPA Approval for Pediatric Clinical Study

CompanyDrug

Boehringer Ingelheim and Eli Lilly’s Jardiance Approved by EC for Chronic Kidney Disease

Company

Biogen’s Q2 2023 Report Reveals Struggles with Aduhelm and 1,000 Job Cuts

CompanyDrug

FDA Approves Daiichi Sankyo’s Vanflyta for FLT3-ITD Positive AML Maintenance Treatment

CompanyDrug

Gilead Sciences Halts Development of Magrolimab for HR-MDS Following Phase III Trial Results

Policy / Regulatory

EU Commits EUR 3 Million to Strengthen Healthcare Access in Latin America and Caribbean